This axon degeneration triggered by ac-tau also leads to neurodegeneration and cognitive impairment after TBI, and pharmacologically reducing ac-tau after TBI via multiple mechanisms rescued neurodegeneration and cognitive impairment [25]. The gene discussed is MAPT; the disease is Cognitive impairment.